Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetracycline repressor protein (TetR) is a bacterial transcription factor that serves as the primary regulator of tetracycline resistance (UniProt P04483). It belongs to the TetR family of regulators (TFRs), which are one-component signal transduction systems common in prokaryotes that sense environmental cues to modulate gene expression (Ramos et al., 2005). TetR functions as a homodimer that binds to specific operator DNA sequences in the absence of tetracycline, thereby repressing the transcription of the TetA efflux pump (Wikipedia). When tetracycline enters the cell and binds to TetR as a magnesium complex, it induces an allosteric conformational change that reduces the protein's affinity for DNA (Deng et al., 2013). This release allows for the expression of the efflux pump, which removes the antibiotic from the cell and confers resistance (Cuthbertson & Nodwell, 2013). Beyond its role in resistance, TetR is a cornerstone of synthetic biology, used to create inducible gene expression systems like Tet-On and Tet-Off (Wikipedia). Understanding TetR is critical for developing strategies to combat antibiotic resistance and for engineering precise genetic controls in biotechnology.
Tetracyclines bind to the TetR protein as a magnesium-complex ([Tc:Mg]2+), inducing an allosteric conformational change that leads to the dissociation of TetR from the operator DNA (tetO), thereby allowing the transcription of resistance genes such as the TetA efflux pump (Ramos et al., 2005; UniProt P04483).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetracycline repressor protein (TetR).